Skip to content

Sellas Life Sciences

US · SLS #2687 by market cap Listed 1970
13.66 -1.20 -8.08%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:58

About Sellas Life Sciences

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Founded
2006
CEO
Dr. Angelos M. Stergiou, M.D.,Sc.D.
Employees
13
Headquarters
New York, New York, United States of America
Fiscal year end
12-31
Website
sellaslifesciences.com

Company profile

Exchange
US
Symbol
SLS
Market-cap rank
#2687
Listing date
1970-01-01
Market cap
2.78B
Float cap
2.77B
Shares out
203.86M
Float shares
203.06M

Sectors & themes

Browse all sectors & themes

Quote time 2026-11-20 19:58:45 · For reference only, not investment advice and not tailored to your situation.

Sellas Life Sciences discussion 0 comments

Add a comment